Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters











Publication year range
1.
Sao Paulo Med J ; 127(1): 52-4, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19466296

ABSTRACT

CONTEXT: Lead poisoning due to retained gunshot bullets is a well-known clinical problem that is fairly frequently described in the literature. The risk factors for this occurrence relate mainly to whether the lead bullet is in contact with the joint fluid or cerebrospinal fluid (CSF). The treatment for these cases entails chelation therapy while symptoms are shown and definitive surgical removal of the bullet as a potential source of lead. The aim of this paper is to describe a clinical case of lead poisoning due to a retained gunshot bullet in contact with CSF. CASE REPORT: A 42-year-old male was hit by gunshot bullets during a holdup, and one of them was retained in the spinal cord. Six years later, he developed intense low back pain and underwent laminectomy. Nine years later, he then underwent arthrodesis on L5-S1, but he developed intense abdominal pain after the surgical procedure. For five years, he was treated with calcium versenate in five-day cycles, with a good response. The chelation therapy cycles showed great efficacy during symptomatic periods, thus reducing the symptoms and signs of poisoning and promoting great amounts of lead excretion, thereby reducing the total lead burden responsible for the symptoms. Fortunately, over the last four years, the symptoms have improved and the urine levels of aminolevulinic acid (ALA) have declined, to reach complete normalization. This shows that a healing process is probably taking place on the spinal wound, thereby isolating the bullet fragments from CSF contact.


Subject(s)
Lead Poisoning/etiology , Wounds, Gunshot/complications , Adult , Chelating Agents/therapeutic use , Chelation Therapy , Edetic Acid/therapeutic use , Humans , Lead Poisoning/cerebrospinal fluid , Lead Poisoning/drug therapy , Lead Poisoning, Nervous System, Adult/etiology , Male
2.
São Paulo med. j ; 127(1): 52-54, Jan. 2009. ilus, graf, tab
Article in English | LILACS | ID: lil-513106

ABSTRACT

CONTEXT: Lead poisoning due to retained gunshot bullets is a well-known clinical problem that is fairly frequently described in the literature. The risk factors for this occurrence relate mainly to whether the lead bullet is in contact with the joint fluid or cerebrospinal fluid (CSF). The treatment for these cases entails chelation therapy while symptoms are shown and definitive surgical removal of the bullet as a potential source of lead. The aim of this paper is to describe a clinical case of lead poisoning due to a retained gunshot bullet in contact with CSF. CASE REPORT: A 42-year-old male was hit by gunshot bullets during a holdup, and one of them was retained in the spinal cord. Six years later, he developed intense low back pain and underwent laminectomy. Nine years later, he then underwent arthrodesis on L5-S1, but he developed intense abdominal pain after the surgical procedure. For five years, he was treated with calcium versenate in five-day cycles, with a good response. The chelation therapy cycles showed great efficacy during symptomatic periods, thus reducing the symptoms and signs of poisoning and promoting great amounts of lead excretion, thereby reducing the total lead burden responsible for the symptoms. Fortunately, over the last four years, the symptoms have improved and the urine levels of aminolevulinic acid (ALA) have declined, to reach complete normalization. This shows that a healing process is probably taking place on the spinal wound, thereby isolating the bullet fragments from CSF contact.


CONTEXTO: A intoxicação por chumbo devida a projétil retido em ferimento por arma de fogo é uma complicação já conhecida e descrita na literatura. O risco de intoxicação endógena por chumbo está associado ao contato do projétil com o líquido sinovial ou líquido o cefalorraquidiano. O tratamento requer terapia de quelação e retirada cirúrgica do projétil como tratamento definitivo. Este artigo descreve caso clínico de paciente que desenvolveu intoxicação por chumbo devida a projétil retido em contato com líquido cefalorraquidiano. RELATO DE CASO: Paciente masculino, 42 anos, foi baleado durante assalto e teve projéteis que se alojaram no abdômen, perna direita e coluna lombo-sacra. Seis anos depois, desenvolveu intensa lombociatalgia e foi submetido a laminectomia. Nove anos após o acidente, foi submetido a artrodese de L5-S1, quando foi tentada a retirada do projétil, sem sucesso, desenvolvendo no pós-operatório intensa dor abdominal. Foi então feito diagnóstico de intoxicação por chumbo, que foi tratada com gluconato de cálcio, com boa resposta. Durante os cinco anos seguintes, fez ciclos de quelação com ácido etilenodiaminotetracético (EDTA) cálcico, com boa evolução. Os ciclos de quelação mostraram grande eficácia na redução dos sinais e sintomas da intoxicação, promovendo um grande aumento da excreção de chumbo e reduzindo a carga corpórea total de chumbo responsável pelos sintomas. Nos últimos quatro anos, apresentou melhora dos sintomas de intoxicação, com diminuição dos níveis de ALA urinário até a normalização, mostrando que provavelmente houve um processo de cicatrização da lesão, isolando os fragmentos de chumbo do contato com o líquor.


Subject(s)
Adult , Humans , Male , Lead Poisoning/etiology , Wounds, Gunshot/complications , Chelating Agents/therapeutic use , Chelation Therapy , Edetic Acid/therapeutic use , Lead Poisoning, Nervous System, Adult/etiology , Lead Poisoning/cerebrospinal fluid , Lead Poisoning/drug therapy
3.
Postepy Biochem ; 52(3): 320-9, 2006.
Article in Polish | MEDLINE | ID: mdl-17201068

ABSTRACT

This article presents the latest study results on lead (Pb2+) neurotoxicity, in order to draw attention of the Polish public to the issue and initiate a nation-wide programme eliminating lead contamination effects, especially in children. We discuss the after-effect of exposure to lead in concentrations lower than presently accepted as 'safe'. The pathway of lead transport to the brain, and the effects of lead accumulation in neurons, oligodendroglia and astroglia, are examined. We also present the impairing influence of lead on the cognitive brain functions and learning abilities as a result of affecting three main neurotransmission systems: dopaminergic, cholinergic and glutaminergic. The present knowledge on the influence of lead on receptors, neutransmitter release and synaptic proteins.


Subject(s)
Behavior, Animal/drug effects , Brain Chemistry/drug effects , Lead Poisoning/blood , Lead Poisoning/cerebrospinal fluid , Lead/toxicity , Receptors, N-Methyl-D-Aspartate/drug effects , Animals , Dose-Response Relationship, Drug , Environmental Exposure , Humans , Lead/metabolism , Lead Poisoning/physiopathology , Lead Poisoning/prevention & control , Lead Poisoning, Nervous System, Childhood/physiopathology , Neurotoxicity Syndromes/physiopathology , Neurotransmitter Agents/poisoning , Rats
4.
Toxicol Sci ; 61(1): 107-14, 2001 May.
Article in English | MEDLINE | ID: mdl-11294981

ABSTRACT

Transthyretin (TTR), synthesized by the choroid plexus, is proposed to have a role in transport of thyroid hormones in the brain. Our previous studies in animals suggest that sequestration of lead (Pb) in the choroid plexus may lead to a marked decrease in TTR levels in the cerebrospinal fluid (CSF). The objectives of this study were to establish in humans whether TTR and thyroxine (T(4)) are correlated in the CSF, and whether CSF levels of Pb are associated with those of TTR, T(4), and/or retinol-binding protein (RBP). Eighty-two paired CSF and blood/serum samples were collected from patients undergoing clinical diagnosis of CSF chemistry. Results showed that the mean value of CSF concentrations for TTR was 3.33 +/- 1.60 microg/mg of CSF proteins (mean +/- SD, n = 82), for total T(4) (TT(4)) was 1.56 +/- 1.68 ng/mg (n = 82), for RBP was 0.34 +/- 0.19 microg/mg (n = 82), and for Pb was 0.53 +/- 0.69 microg/dl (n = 61 for those above the detection limit). Linear regression analyses revealed that CSF TTR levels were positively associated with those of CSF TT(4) (r = 0.33, p < 0.005). CSF TTR concentrations, however, were inversely associated with CSF Pb concentrations (r = -0.29, p < 0.05). There was an inverse, albeit weak, correlation between CSF TT(4) and CSF Pb concentrations (r = -0.22, p = 0.09). The concentrations of TTR, TT(4), and Pb in the CSF did not vary as the function of their levels in blood or serum, but RBP concentrations in the CSF did correlate to those of serum (r = 0.39, p < 0.0005). Unlike TTR, CSF RBP concentrations were not influenced by PB: These human data are consistent with our earlier observations in animals, which suggest that TTR is required for thyroxine transport in the CSF and that Pb exposure is likely associated with diminished TTR levels in the CSF.


Subject(s)
Lead/analysis , Prealbumin/analysis , Prealbumin/drug effects , Retinol-Binding Proteins/analysis , Retinol-Binding Proteins/drug effects , Thyroxine/analysis , Thyroxine/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Antigen-Antibody Complex/immunology , Child , China , Environmental Exposure , Female , Humans , Iodine/chemistry , Iodine Radioisotopes , Lead/cerebrospinal fluid , Lead Poisoning/cerebrospinal fluid , Male , Prealbumin/cerebrospinal fluid , Precipitin Tests , Radioimmunoassay , Retinol-Binding Proteins/cerebrospinal fluid , Spectrophotometry, Atomic , Statistics as Topic , Thyroxine/cerebrospinal fluid
7.
J Neurol Sci ; 48(3): 413-8, 1980 Dec.
Article in English | MEDLINE | ID: mdl-7441289

ABSTRACT

The lead concentration in CSF was determined by flameless atomic absorption spectrophotometry in 16 ALS patients and 22 control cases. The mean values were 0.69 +/- 0.55 (ALS) and 0.41 +/- 0.37 (controls), P < 0.01. This confirms our earlier findings of raised CSF lead levels in ALS but the present values are lower than previously reported for both ALS patients and controls.


Subject(s)
Amyotrophic Lateral Sclerosis/cerebrospinal fluid , Lead Poisoning/cerebrospinal fluid , Lead/cerebrospinal fluid , Adult , Aged , Female , Humans , Male , Middle Aged
8.
Arch Neurol ; 36(6): 384-5, 1979 Jun.
Article in English | MEDLINE | ID: mdl-222248

ABSTRACT

Adenovirus type 12 was recovered from the CSF of a 36-year-old woman with adenoviral meningoencephalitis and lead toxicity. The serum level of lead was 199 micrograms/dL and the CSF level was 7 micrograms/dL. After therapy with edetate disodium calcium (Calcium Disodium Versenate), she had an uneventful recovery. The possibility of exacerbation of lead poisoning with encephalopathy due to adenovirus type 12 meningoencephalitis is raised.


Subject(s)
Adenoviridae Infections/complications , Adenovirus Infections, Human/complications , Lead Poisoning/complications , Meningoencephalitis/complications , Acute Disease , Adenoviridae/isolation & purification , Adenovirus Infections, Human/microbiology , Edetic Acid/therapeutic use , Lead/blood , Lead/cerebrospinal fluid , Lead Poisoning/blood , Lead Poisoning/cerebrospinal fluid , Lead Poisoning/drug therapy , Meningoencephalitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL